RTRX - Travere Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Travere Therapeutics's activity chart (see below) currently has 49 price targets and 41 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 17.82% of the time, taking 115 days on average.

Most recent stock forecast was given by from on 06-Nov-2020. First documented stock forecast 12-Feb-2014.

Best performing analysts who are covering RTRX - Travere Therapeutics:

Gena Wang Robyn Karnauskas Do Kim

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Mar-2015

$33

$31

6 years 15 days ago
(06-Nov-2020)

3/13 (23.08%)

$11.43 (52.99%)

416

$36

6 years 15 days ago
(05-Nov-2020)

0/1 (0%)

$36 (0.00%)

Buy Since 22-Apr-2019

$30

$19

6 years 2 months 28 days ago
(24-Aug-2020)

2/4 (50%)

$10.98 (57.73%)

217

Buy Since 30-Oct-2018

$38

$44

6 years 3 months 23 days ago
(29-Jul-2020)

0/2 (0%)

$17.8 (88.12%)

Buy Since 23-Aug-2019

$19

$20

6 years 8 months 27 days ago
(25-Feb-2020)

2/2 (100%)

$4.6 (31.94%)

217

Show more analysts

Please expand the browser size to see the chart

What is RTRX (Travere Therapeutics) average time for price targets to be met?

On average it took 115 days for the stock forecasts to be reached, with an average price target met ratio of 17.82%.

Which analyst most recently updated their price target on RTRX (Travere Therapeutics)?

Which analyst has the most public recommendations on RTRX (Travere Therapeutics)?

has 0 price targets and 0 ratings on RTRX

Which analyst is the currently most bullish on RTRX (Travere Therapeutics)?

Robyn Karnauskas with the highest potential upside of $27.34

Which analyst is the currently most reserved on RTRX (Travere Therapeutics)?

Gena Wang with the lowest potential downside of -$5.66
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?